mdl 72527 and Adenocarcinoma, Basal Cell

mdl 72527 has been researched along with Adenocarcinoma, Basal Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amlong, CA; Basu, HS; Church, DR; Clower, CC; Lindstrom, MJ; Martin, CT; Mehraein-Ghomi, F; Thompson, TA; Wilding, G; Woster, PM1
Agostinelli, E; Arancia, G; Belli, F; Condello, M; Seiler, N; Vedova, LD1
Blanchard, Y; Chamaillard, L; Cipolla, B; Guillé, F; Havouis, R; Moulinoux, JP; Quemener, V1
Cipolla, B; Guillé, F; Havouis, R; Lobel, B; Martin, C; Moulinoux, JP; Quemener, V; Seiler, N1
Brasitus, TA; Chowdhury, LN; Davidson, NO; Dudeja, PK; Halline, AG; Jacoby, RF; Llor, X; Teng, BB1

Other Studies

5 other study(ies) available for mdl 72527 and Adenocarcinoma, Basal Cell

ArticleYear
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.
    Cancer research, 2009, Oct-01, Volume: 69, Issue:19

    Topics: Acetyltransferases; Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Male; Mice; Mice, Transgenic; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Prostatic Neoplasms; Putrescine; Reactive Oxygen Species; RNA, Small Interfering

2009
Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound.
    International journal of oncology, 2006, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Aldehydes; Amine Oxidase (Copper-Containing); Animals; Antineoplastic Combined Chemotherapy Protocols; Cattle; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; Hydrogen Peroxide; Lysosomes; Putrescine; Reactive Oxygen Species; Spermine; Tumor Cells, Cultured

2006
In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
    Urological research, 1996, Volume: 24, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Eflornithine; Lung Neoplasms; Male; Metronidazole; Neomycin; Oxidoreductases Acting on CH-NH Group Donors; Polyamines; Prostatic Neoplasms; Protein Synthesis Inhibitors; Putrescine; Rats; Rats, Inbred Strains; Survival Rate

1996
The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation.
    The Journal of urology, 1991, Volume: 146, Issue:5

    Topics: Adenocarcinoma; Animals; Diet; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Eflornithine; Male; Neomycin; Neoplasm Transplantation; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Prostatic Neoplasms; Putrescine; Rats; Rats, Inbred Strains

1991
Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine.
    Carcinogenesis, 1990, Volume: 11, Issue:12

    Topics: 1,2-Dimethylhydrazine; Acetyltransferases; Adenocarcinoma; Animals; Base Sequence; Carcinogens; Colon; Colonic Neoplasms; Dimethylhydrazines; Genes, ras; Male; Molecular Sequence Data; Neoplasms, Experimental; Ornithine Decarboxylase; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polymerase Chain Reaction; Putrescine; Rats; Rats, Inbred Strains

1990